Literature DB >> 12854928

Spinal and epidural versus general anesthesia for elective cesarean section at term: effect on the acid-base status of the mother and newborn.

G Petropoulos1, C Siristatidis, E Salamalekis, G Creatsas.   

Abstract

OBJECTIVE: To compare general, epidural and combined spinal-epidural anesthesia with respect to short-term outcome of newborns delivered by elective Cesarean section of healthy parturients with normal pregnancies. STUDY
DESIGN: A total of 238 eight pregnant women admitted to our institution between January 1998 and July 2002, for whom elective Cesarean section was planned after 38 weeks' gestation, were grouped according to the kind of anesthesia used for the procedure. Maternal characteristics, birth weight, Apgar scores, and maternal and umbilical artery (UA) acid-base parameters were analyzed.
RESULTS: Maternal pH was significantly lower and pCO2: and pO2 were significantly higher in the general anesthetic group, compared to the other two groups (7.38 +/- 0.03 vs. 7.43 +/- 0.02 and 7.43 +/- 0.05, respectively; 35.03 +/- 3.88 mmHg vs. 29.25 +/- 5.05 mmHg and 29.64 +/- 4.16 mmHg, respectively; and 224.56 +/- 86.77 mmHg vs. 151.28 +/- 38 mmHg and 157.36 +/- 53.51 mmHg, respectively, p < 0.05). The pH of the UA was higher in the general anesthetic group, compared to the spinal-epidural group (7.29 +/- 0.02 vs. 7.26 +/- 0.06, p < 0.05). The pO2 as well as O2 saturation of the UA were higher when general anesthetic was administered, compared to the two regional modalities (15.60 +/- 5.48 mmHg vs. 9.29 +/- 4.41 mmHg and 9.20 +/- 4.06 mmHg, respectively; and 17.37 +/- 9.79% vs. 7.87 +/- 4.98% and 6.90 +/- 5.22%, respectively, p < 0.05). UA O2 saturation fell to zero in some cases in the combined spinal-epidural group, without an evident effect on fetal well-being. No fetal acidemia was noted in any group. Neonatal outcomes were similar in the three groups studied.
CONCLUSIONS: Type of anesthesia does not influence short-term outcomes in infants born via elective Cesarean section, although differences in acid-base status of both the mother and especially the newborn recommend careful use of spinal anesthesia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854928     DOI: 10.1080/jmf.13.4.260.266

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

Review 1.  [Recent standards in management of obstetric anesthesia].

Authors:  Maximiliaan van Erp; Clemens Ortner; Stefan Jochberger; Klaus Ulrich Klein
Journal:  Wien Med Wochenschr       Date:  2017-07-25

Review 2.  Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews.

Authors:  Joanne Guay; Peter Choi; Santhanam Suresh; Natalie Albert; Sandra Kopp; Nathan Leon Pace
Journal:  Cochrane Database Syst Rev       Date:  2014-01-25

3.  The Effect of Spinal and General Anesthesia on Serum Lipid Peroxides and Total Antioxidant Capacity in Diabetic Patients with Lower Limb Amputation Surgery.

Authors:  Arash Peivandi Yazdi; Alireza Bameshki; Maryam Salehi; Gholamhosein Kazemzadeh; Majid Sharifian Razavi; Shaghayegh Rahmani; Seyed Isaac Hashemy
Journal:  Arch Bone Jt Surg       Date:  2018-07

Review 4.  Supplemental oxygen for caesarean section during regional anaesthesia.

Authors:  Sunisa Chatmongkolchart; Sumidtra Prathep
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16

5.  The Type of Anesthesia Used during Cesarean Section Is Related to the Transient Tachypnea of the Newborn.

Authors:  Esengül Keleş; Hamza Yazgan; Arzu Gebeşçe; Emine Pakır
Journal:  ISRN Pediatr       Date:  2013-04-24

6.  Appropriate Method of Administering Vasopressors for Maternal Hypotension Associated with Combined Spinal Epidural Anesthesia in Elective Cesarean Section: Impact on Postnatal Respiratory Support for Newborns.

Authors:  Shoichi Magawa; Masafumi Nii; Yosuke Sakakura; Naosuke Enomoto; Sho Takakura; Shintaro Maki; Hiroaki Tanaka; Eiji Kondo; Tomoaki Ikeda
Journal:  Medicina (Kaunas)       Date:  2022-03-08       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.